| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.28 | 0.1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |